Diameter Changes in Traumatic Aortic Injury: Implications for Stent-Graft Sizing.


Journal

The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 30 7 2020
medline: 29 6 2022
entrez: 30 7 2020
Statut: ppublish

Résumé

The aim of this study was to compare aortic diameters from admission computed tomography angiography (CTA) scans to postoperative aortic diameters in patients with traumatic aortic injury (TAI) and evaluate the influence of substantial blood loss on aortic diameter. The aortic databases of two tertiary university centers were retrospectively screened for patients with TAI between February 2002 and February 2019. Concomitant organ injuries, bone fractures, blood loss, and clinical outcomes were evaluated. Aortic diameters were measured in CTA upon admission and were compared with the CTA before discharge at three different aortic levels (mid-ascending, 5 cm distal to the end of the stent graft, and at the celiac trunk level). We identified 45 patients, aged 43 (first quartile; third quartile [26; 55]) years with a TAI treated by thoracic endovascular aortic repair. The most frequent cause of TAI was a car accident ( In patients with TAI, the aortic diameter is significantly reduced as compared with the aortic diameter at discharge. The reduction of aortic diameter might be caused by hemorrhagic shock and should be kept in mind for appropriate stent-graft sizing.

Identifiants

pubmed: 32725612
doi: 10.1055/s-0040-1713425
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

333-338

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Auteurs

Tim Berger (T)

Department of Cardiovascular Surgery, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Baden Württemberg, Germany.

Andreas Voetsch (A)

Department of Cardiovascular and Endovascular Surgery, Paraclesus Medical University Salzburg, Salzburg, Austria.

Diaa Alaloh (D)

Department of Cardiovascular Surgery, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Baden Württemberg, Germany.

Maximilian Kreibich (M)

Department of Cardiovascular Surgery, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Baden Württemberg, Germany.

Philipp Krombholz-Reindl (P)

Department of Cardiovascular and Endovascular Surgery, Paraclesus Medical University Salzburg, Salzburg, Austria.

Andreas Winkler (A)

Department of Cardiovascular and Endovascular Surgery, Paraclesus Medical University Salzburg, Salzburg, Austria.

Bartosz Rylski (B)

Department of Cardiovascular Surgery, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Baden Württemberg, Germany.

Thomas Wolfgruber (T)

Universit Institute for Radiology, Paraclesus Medical University Salzburg, Salzburg, Austria.

Friedhelm Beyersdorf (F)

Department of Cardiovascular Surgery, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Baden Württemberg, Germany.

Matthias Siepe (M)

Department of Cardiovascular Surgery, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Baden Württemberg, Germany.

Rainald Seitelberger (R)

Department of Cardiovascular and Endovascular Surgery, Paraclesus Medical University Salzburg, Salzburg, Austria.

Martin Czerny (M)

Department of Cardiovascular Surgery, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Baden Württemberg, Germany.

Roman Gottardi (R)

Department of Cardiovascular and Endovascular Surgery, Paraclesus Medical University Salzburg, Salzburg, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH